Primer: Golden Throat (6896 HK) - Aug 2026
Dominant Brand Facing Headwinds: Golden Throat is a leading and well-recognized manufacturer of lozenges in China, with its flagship Golden...
94 Views
Golden Throat (6896 HK): China’s Leading Lozenge Maker at 10x P/E and a 10% Dividend Yield
Golden Throat (6896 HK — US$343 million) is an iconic Chinese brand of throat lozenges, used to deal with sore or dry throats. The core product is...
655 Views
Henlius (2696 HK): So, When Was The Last Time A PE/VC Outfit Blocked A Deal?
PE and/or a VC outfit blocking deals are rare. Which may suggest LVC doesn't want that moniker. You could therefore, extrapolate that line of...
1.1k Views
Asian Dividend Gems: Golden Throat Holdings
Golden Throat Holdings is one of the leading throat lozenges manufacturers in China. It has an eye-catching dividend yield (17.9% in 2023) and a...
910 Views
Golden Throat (6896 HK): This One Left A Bitter Aftertaste
There is something totally off about this deal. Currently trading at $1.60/share, 11.1% below the "true" undisturbed price. I wouldn't touch this....
728 Views